Abstract. Objectives. Obesity is prevalent with nearly one third of the world's population being classified as obese. Total knee arthroplasty (TKA) is an effective treatment option for high BMI patients achieving similar outcomes to non-obese patients. However, increased rates of aseptic loosening in patients with a high BMI have been reported. In patients with high BMI/body mass there is an increase in strain placed on the implant fixation interfaces. As such component fixation is a potential concern when performing TKA in the obese patient. To address this concern the use of extended tibial stems in cemented implants or cementless fixation have been advocated. Extend tibial stems are thought to improve implant stability reducing the micromotion between interfaces and consequently the risk of aseptic loosening. Cementless implants, once biologic fixation is achieved, effectively integrate into bone eliminating an interface. This retrospective study compared the use of extended tibial stems and cementless implants to conventional cemented implants in high BMI patients. Methods. From a prospectively maintained database of 3239 primary Attune TKA (Depuy, Warsaw, Indiana), obese patients (body mass index (BMI) >30 kg/m²) were retrospectively reviewed. Two groups of patients 1) using a tibial stem extension [n=162] and 2) cementless fixation [n=163] were compared to 3) a control group (n=1426) with a standard tibial stem cemented implant. All operations were performed by or under the direct supervision of specialist arthroplasty surgeons. Analysis compared the groups with respect to class I, II, and III (BMI >30kg/m², >35 kg/m², >40 kg/m²) obesity. The primary outcome measures were all-cause revision, revision for aseptic loosening, and revision for tibial loosening. Kaplan-Meier survival analysis and Cox regression models were used to compare the primary outcomes between groups. Where radiographic images at greater than 3 months post-operatively were available, radiographs were examined to compare the presence of peri-implant radiolucent lines. Results. The mean follow-up of 4.8, 3.4, and 2.5 years for cemented, stemmed, and cementless groups respectively. In total there were 34 all-cause revisions across all the groups with revision rates of 4.55, 5.50, and 0.00 per 1000-implant-years for cemented, stemmed, and cementless groups respectively. Survival Analysis did not show any significant differences between the three groups for all-all cause revision. There were 6 revisions for aseptic loosening (5 tibial and 1 femoral); all of which were in the standard cemented implant group. In contrast there were no revisions in the stemmed or cementless implant groups, however, this was not significant on survival analysis. Analysis looking at class I, II, and III obesity also did not show any significant differences in survival for all cause revision or aseptic loosening. Conclusion. This retrospective analysis showed that there were no revisions required for aseptic loosening when either a cemented stemmed or cementless implant were used in obese patients. These findings are in line with other studies showing that cementless fixation or extended stem implants are a reasonable option in obese patients who represent an increasing cohort of patients requiring TKR. Declaration of Interest. (b) declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported:I declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research project

Summary Statement. The current biomecahnical study demonstrated that the stemless peripheral leg humeral component prototype and central screw humeral component prototype achieved similar initial fixation as stemmed Global Advantage humeral component in terms of resultant micromotion in total shoulder arthroplasty. Introduction. A stemless humeral component may offer a variety of advantages over its stemmed counterpart, e.g. easier implantation, preservation of humeral bone stock, fewer humeral complications, etc. However, the initial fixation of a stemless humeral component typically depends on cementless metaphyseal press-fit, which could pose some challenges to the initial stability. Long-term success of cementless implants is highly related to osseous integration, which is affected by initial implant-bone interface motion. 1. The purpose of the study was to biomechanically compare micromotion at the implant-bone interface of three humeral components in total shoulder arthroplasty. Patients & Methods. Three humeral components were evaluated: Global Advantage, a central screw prototype, and a peripheral leg prototype. All components were the smallest sizes available. Global Advantage is a stemmed design. Both central screw prototype and peripheral leg prototype are stemless designs. Five specimens were tested for each design. Composite analogue humeral models were utilized to simulate the humeral bone. The cortical wall had a thickness of 3 mm and a density of 481 kg/m. 3. , while the cancellous density was 80 kg/m. 3. The model was custom fabricated to accommodate 40 mm humeral component and had a 45° resected surface and a square base to facilitate test setup. Each humeral component was implanted per its surgical technique. The construct was clamped in a vise with the humeral shaft angled at 27°. A MTS test system was employed to conduct the test. A sinusoidal compressive load from 157 N to 1566 N (2BW) was applied to the humeral component at 1 Hz for 100 cycles. The implant-bone interface micromotion was measured with a digital image correlation system which had a resolution of less than 1 micron. The micromotion measurement was transformed to 2 components: 1 was parallel and the other perpendicular to the humeral resection surface. Peak-valley micromotion from the last 10 cycles were averaged and utilised for data analyses. A one-way ANOVA and post-hoc Tukey tests were performed to compare the micromotion of different designs (α=0.05). Results. Micromotion of Global Advantage parallel to the resection (X-Axis) was significantly less than that of central screw prototype and peripheral leg prototype. Micromotion of peripheral leg prototype perpendicular to the resection (Y-Axis) was significantly less than Global Advantage and central screw prototype. There was no significant difference between different designs in resultant micromotion. Discussion/Conclusion. Clinical studies have shown that current stemless shoulder prosthesis yielded encouraging results in mid-term follow-ups. Particularly, the stemless Arthrex Eclipse humeral component, a central screw design, has been reported to have a secure bony fixation and ingrowth at an average of 23 months postoperatively. 4. The current study demonstrated that the stemless peripheral leg prototype and central screw prototype achieved similar initial fixation as stemmed Global Advantage in terms of resultant micromotion, and provided biomechanical evidence that stemless humeral components could have comparable initial stability to stemmed counterparts

Wear of polyethylene is associated with aseptic loosening of orthopaedic implants and has been observed in hip and knee prostheses and anatomical implants for the shoulder. The reversed shoulder prostheses have not been assessed as yet. We investigated the volumetric polyethylene wear of the reversed and anatomical Aequalis shoulder prostheses using a mathematical musculoskeletal model. Movement and joint stability were achieved by EMG-controlled activation of the muscles. A non-constant wear factor was considered. Simulated activities of daily living were estimated from in vivo recorded data.

After one year of use, the volumetric wear was 8.4 mm³ for the anatomical prosthesis, but 44.6 mm³ for the reversed version. For the anatomical prosthesis the predictions for contact pressure and wear were consistent with biomechanical and clinical data. The abrasive wear of the polyethylene in reversed prostheses should not be underestimated, and further analysis, both experimental and clinical, is required.